文献速递焦虑、强迫与应激相关障碍

艾司西酞普兰或正念冥想治疗焦虑障碍后焦虑增强惊跳反应的衰减

Attenuation of Anxiety-Potentiated Startle After Treatment With Escitalopram or Mindfulness Meditation in Anxiety Disorders.
PubMed 文献 · Biol Psychiatry · 2023-06-16

患者随机接受8周艾司西酞普兰或正念减压治疗。基线时患者焦虑增强惊跳(APS)高于对照,两种治疗均显著降低APS至对照水平,但对恐惧增强惊跳(FPS)无影响。

要点

  • 焦虑障碍患者基线APS高于健康对照,FPS无差异。
  • 艾司西酞普兰和正念减压均显著降低APS,效果相当。
  • 两种治疗对可预测威胁的FPS均无显著影响。

核心结论

  • 艾司西酞普兰和正念减压治疗均降低焦虑障碍患者对不可预测威胁的惊跳增强(APS),但不影响对可预测威胁的惊跳增强(FPS)。

主要发现

  • 基线时焦虑障碍患者APS高于健康对照,FPS无显著差异。
  • 两种治疗组APS下降幅度均显著大于对照组,治疗结束时患者APS降至健康对照范围。

临床怎么用

  • APS可作为病理性焦虑的生物学相关指标,并用于评估正念减压和艾司西酞普兰对焦虑神经环路的治疗效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Biological markers for anxiety disorders may further understanding of disorder pathophysiology and suggest potential targeted treatments. The fear-potentiated startle (FPS) (a measure of startle to predictable threat) and anxiety-potentiated startle (APS) (startle to unpredictable threat) laboratory paradigm has been used to detect physiological differences in individuals with anxiety disorders compared with nonanxious control individuals, and in pharmacological challenge studies in healthy adults. However, little is known about how startle may change with treatment for anxiety disorders, and no data are available regarding alterations due to mindfulness meditation training. METHODS: Ninety-three individuals with anxiety disorders and 66 healthy individuals completed 2 sessions of the neutral, predictable, and unpredictable threat task, which employs a startle probe and the threat of shock to assess moment-by-moment fear and anxiety. Between the two testing sessions, patients received randomized 8-week treatment with either escitalopram or mindfulness-based stress reduction. RESULTS: APS, but not FPS, was higher in participants with anxiety disorders compared with healthy control individuals at baseline. Further, there was a significantly greater decrease in APS for both treatment groups compared with the control group, with the patient groups showing reductions bringing them into the range of control individuals at the end of the treatment. CONCLUSIONS: Both anxiety treatments (escitalopram and mindfulness-based stress reduction) reduced startle potentiation during unpredictable (APS) but not predictable (FPS) threat. These findings further validate APS as a biological correlate of pathological anxiety and provide physiological evidence for the impact of mindfulness-based stress reduction on anxiety disorders, suggesting that there may be comparable effects of the two treatments on anxiety neurocircuitry.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Hoge EA, Armstrong CH, Mete M, et al. Attenuation of Anxiety-Potentiated Startle After Treatment With Escitalopram or Mindfulness Meditation in Anxiety Disorders. Biol Psychiatry. 2023. PMID: 37331547. doi:10.1016/j.biopsych.2023.06.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。